SUPPLEMENTARY FIGURES Supplementary Figure S1. Time course of ligand binding and unbinding. Superimposition of six normalized individual traces (grey) and the resulting respective averaged trace (black) for ligand binding and unbinding. The fcGMP concentration was stepped from 0 µM to 12 µM and back to 0 µM. 3 Supplementary Figure S2. Fit of ligand binding and unbinding as well as channel activation and deactivation with the C4L model. (a) Scheme of the C4L model. C x and O x (x = 0…4) denote closed and open states, respectively. L is a ligand. Rate constants set equal in the fit are indicated by using the same colours. E x are the equilibrium constants for the closed-open isomerizations and K ACx,x+1 are equilibrium association constants. (b) Time courses of ligand binding and unbinding (green) as well as activation and deactivation (black) for three fcGMP concentrations. The concentration jumps from 0 to the respective fcGMP concentrations and back to 0 are 4 indicated by the beginning and the end of the black bar above each trace, respectively. (c) Steady-state relationships for activation (left, black symbols) and ligand binding (right, green symbols). The red curves in b and c are the result of the best global fit of the time courses of ligand binding, ligand unbinding, activation, and deactivation as well as the steady-state relationships with the C4L model. The model does not fit the time courses of ligand unbinding and deactivation at the same time. The reduced χ r 2 was 21.5. 5 Supplementary Figure S3. 6 7
Selection of tested alternative models with ligand unbinding via the states C x , O x and/or
*O x . Rate constants set equal in the fitting strategy are shown in equal color. The number of parameters and the reduced χ r 2 values of the fit are provided at the right side. Supplementary Table S1 . Rate and equilibrium constants determined for the C4L model when fitting the time courses of ligand binding and channel activation in addition to the two steady-state relationships (see scheme below; Fig. 2a ).
SUPPLEMENTARY TABLES

Rate constant Equilibrium constant
Value indicates the standard error in %. These values were taken from the main diagonal of the covariance matrix of the fit. In the fit the following rate constants were set equal: Supplementary Table S2 . Rate and equilibrium constants determined for the C4L-*O4L model (see scheme below; Fig. 3a ). # indicates that the values were set to the diffusion limit 18 (see text); n.d. means not determined.
The nomenclature corresponds to that in Supplementary Table S1 .
SUPPLEMENTARY METHODS
Fitting kinetic models. To determine the rate and/or equilibrium constants for a given model, 
The trace number, n t , denotes the number of concentrations analyzed. Its value was 3. The to be fitted is much bigger than those in the steady-state relationships, we employed the factor g = n s /(n d ×n t ) to give the time courses and the steady-state relationships the same weight in the fit. In our fit procedure, the time courses of ligand binding and activation were not fitted with their absolute amplitude. Instead they were normalized with respect to the late amplitude in the presence of the ligand. The same normalization was used for the corresponding time courses of unbinding and deactivation. Hence, in the fit the "shape" of the traces was fitted.
In addition to the traces, ligand binding and activation under steady-state conditions was included by 10 data points each, covering the concentration range between 0.03 and 29.1 µM fcGMP ( Figs. 2c, 3c , and Supplementary Fig. S2 ). In the global fit the total of the traces and the total of steady steady-state values were weighted by 50% each, thereby weighting each of the 396 sampling points with g = n s /(n d ×n t ) = 0.05. This means, that the effective number of points to be fitted in the current-and fluorescence time courses equals the number of the concentrations values in the steady-state data, n s . The fitting procedure minimized χ 2 .
The reduced χ 2 value for the global fit was obtained by dividing χ 2 by the degrees of freedom of the fit according to With the unusual stringency in our global fits, the best value for the C4L-*O4L model was about 6.0 (Fig. 3) . The standard errors of the fitted parameters were obtained from the covariance matrix and the χ 2 hypersurface.
Some further general rules were adopted for the fit:
1. In models containing cycles, the principle of microscopic reversibility was taken into account. This means that within a cycle the product of the rate constants in the forward direction equals the product of the rate constants in the backward direction. This reduced the number of rate constants to be fitted in each cycle by one.
2. If rate constants were not determined with reasonable accuracy (standard error > 45%), equally directed rate constants were equated and it was then tested whether the quality of the fit (evaluated by χ 2 ) was kept. If χ 2 was not increased by equating two rate constants, the manoeuvre was accepted.
3. The transitions C 2 ↔O 2 and C 3 ↔O 3 were assumed to be equal because the fit did not allow us to differentiate them.
Calculation of the rate constants with the C4L model. The C4L model described previously 10 for the steady-state binding and activation by fcGMP as well as activation gating by cGMP is shown in the following scheme.
Scheme of the C4L model
Closed and open states are symbolized by C x and O x , respectively. L is the ligand concentration in M. The rate constants, k XY , characterize the transitions from state X to state Y. Their values at zero and saturating fcGMP were taken from single-channel experiments 10 to be k O0C0 = 9.0×10 2 s -1 , k C0O0 = 1.0×10 -1 s -1 , k O4C4 = 4.1×10 0 s -1 , k C4O4 = 4.0×10 2 s -1 , resulting
in closed-open isomerization constants E 0 =k C0O0 /k O0C0 = 1.1×10 -4 and E 4 = k C4O4 /k O4C4 = 9.9×10 1 , respectively. When setting the remaining 14 rate constants as free parameters, their determinateness was only poor. Similar to our previous report 10 we next reduced the number of free parameters to 8 by setting the following parameters equal: k C0C1 = k C1C2 = k C2C3 = k C3C4 . Assumed was further k C2O2 = k C3O3 and k O2C2 = k O3C3 , resulting in E 2 = E 3 . The resulting fit led to a reasonable determinateness of all parameters apart from k C1O1 and k O1C1 . Because it turned out in all fits that k C1O1 >> k O1C1 we further simplified the fit by setting k C1O1 = k C0O0 and k O1C1 = k O0C0 , i.e. E 1 = E 0 . This resulted in a fit with only 7 free parameters that were fully determined ( Fig. 2a ; Supplementary Table S1 ). Notably, the goodness of the fit did not significantly worsen by reducing the parameter number from 14 to 7, suggesting that the shown deficiencies preferably in the unbinding and deactivation did not depend on a limited number of free parameters but on the structure of the model. The approach described for the C4L model holds in an analogue fashion also for the other tested models.
In all further models tested, we set k O0C0 = 9.0×10 2 s -1 , k C0O0 = 1.0×10 -1 s -1 , k O4C4 = 4.1×10 0 s -1 ,
Calculation of the rate constants with the C4L-*O4L model. The following scheme shows the C4L-*O4L model, which described our data best.
Scheme of the C4L-*O4L model
The states *O x describe a pathway which is practically solely used for deactivation. The rate constants at zero and saturating fcGMP were set as described for the C4L model. This was justified because the *O-pathway is quantitatively only recruited during deactivation after removing the ligand but not during activation, i.e. in the presence of the ligand (see Fig. 6 ). were computed by
Computation
and
respectively. For the closed-open isomerizations the net probability flux density was obtained by
and f C4*O4 (t) = k C4*O4 ×C 4 (t)-k *O4C4 ×*O 4 (t),
respectively. The procedure has been described in detail previously 13 .
The total net probability fluxes between two neighbored states, F XY , were obtained by computing the following time integral
For ligand binding and activation t 0 is the time at which the ligand was applied and t end the time just before the ligand was removed. Correspondingly, for ligand unbinding and deactivation t 0 is the time at which the ligand was removed and t end the time at the end of the recording. Hence, F XY indicates how much of the total net probability flux moves along a transition X↔Y.
Transition pathway analysis. If a Markovian model is fully reversible, the total probability flux can easily be decomposed into the pathway net probability fluxes as described previously for HCN2 channels 13 . In brief, to analyze the pathway p from state X 0 to state X k along the states X i , first the net probability flux F p,X0Xk is computed according to F p,X0Xk = min⏐ [F Xi-1Xi ⏐i = 1…k] ⏐ (S10)
Then F p,X0Xk is subtracted from the flux along all edges of this pathway p. Then the analysis procedure is repeated for the remaining pathways until the total probability flux between these states is zero 46 . A useful approach is to start with the strongest pathway 46 .
Consider, for example, at 12 µM fcGMP the transition pathways C 0 *O 4 , C 0 O 3 , C 0 O 2 (red arrows in Fig. 6A ). The net probability fluxes of interest are F C0C1 = 0.9995, F C1C2 = 0.9980, F C2C3 = 0.9397, F C3C4 = 0.8269, F C2O2 = 0.0555, F C3O3 = 0.1076, F C4*O4 = 0.8188. First, the flux along the pathway C 0 *O 4 was computed by F p,C0*O4 = min⏐[F C0C1 , F C1C2 , F C2C3 , F C3C4 , F C4*O4 ]⏐ = 0.82. This value was then subtracted from F C0C1 , F C1C2 , and F C2C3 , yielding F C0C1 ', F C1C2 ', and F C2C3 ', respectively. Then the flux along the pathway C 0 O 3 was obtained by F p,C0O3 = min⏐ [F C0C1 ', F C1C2 ', F C2C3 ',F C3O3 ,]⏐= 0.11. The flux along the pathway C 0 O 2 was obtained in an analogue fashion. The result does not depend on the sequence starting with the strongest pathway.
